Riverside University Health System Medical Center
Moreno Valley, California, 92555, United States
Location status: Recruiting
NCT Number: NCT07686913
This study is evaluating whether Steri-Strips® provide additional benefits when used after cesarean section (C-section) surgery. Steri-Strips are adhesive strips that are commonly placed over a surgical incision to provide support while the wound heals. At our hospital, Steri-Strips are routinely used after C-sections in addition to standard wound closure techniques, although they are not considered part of the standard recommended closure method.
Researchers want to determine whether adding Steri-Strips actually reduces wound complications such as infection, fluid collection under the skin, or reopening of the incision. Previous studies have shown mixed results, with some suggesting little difference in wound healing outcomes while others reported differences in scar appearance. Steri-Strips may also increase costs, add time to the surgery, and occasionally cause skin irritation or allergic reactions.
Participants in this study will be randomly assigned to one of two groups. One group will receive standard cesarean wound closure with Steri-Strips, while the other group will receive standard wound closure without Steri-Strips. Researchers will compare wound healing, complications, patient outcomes, and costs between the two groups.
The goal of this study is to determine whether Steri-Strips improve recovery after cesarean delivery and whether their routine use is beneficial and cost-effective. The findings may help guide future recommendations for cesarean wound care and improve outcomes for patients undergoing C-section delivery.
Interested in participating?
Request Info18 year and older
Female
Interventional
Not applicable
Moreno Valley, California, 92555, United States
Location status: Recruiting
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Application of Steri-Strip adhesive skin closure strips following standard cesarean section wound closure according to a standardized protocol.
Standard skin closure performed following cesarean delivery according to institutional practice.
Time frame: Within 30 days postpartum
Composite incidence of postoperative wound complications including surgical site infection, wound seroma, and wound separation/dehiscence following cesarean delivery.
Time frame: From cesarean delivery until hospital discharge (up to 7 days)
Duration of hospitalization measured from cesarean delivery until discharge.
Time frame: Within 30 days postpartum
Hospital readmission attributable to wound infection, seroma, or wound separation/dehiscence following cesarean delivery.
Time frame: From cesarean delivery through 30 days postpartum
Comparison of direct healthcare costs associated with wound closure materials and management of postoperative wound complications between study groups.
Contact information is provided by the study sponsor or research team.
Riverside University Health System Medical Center
Other
A Randomized Prospective Trial Comparing Steri-Strip Application Versus Standard Wound Closure for Cesarean Section Incisions
Acronym: STRIP-CS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07715409
Adnexal Diseases, Cesarean Section
Damietta, Damietta Governorate, Egypt
View Trial DetailsNCT06558240
Cesarean Section, Genital Diseases
Taipei, Taiwan
View Trial DetailsNCT06770946
Cesarean Section, Cicatrix
Van, Turkey (Türkiye)
View Trial DetailsNCT04681378
Cesarean Section, Wound Dehiscence
View Trial Details